↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Broelsch C) "

Search: WFRF:(Broelsch C)

Result 1-5 of 5

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Mergental, H, et al. (author) Liver transplantation for intrahepatic recurrence of hepatocellular carcinoma in non-cirrhotic livers after partial liver resection 2007 In: TRANSPLANT INTERNATIONAL. - 0934-0874. ; 20, s. 5-5 Conference paper (other academic/artistic)
2.	Mergental, H, et al. (author) Liver Transplantation for Unresectable Hepatocellular Carcinoma in Normal Livers 2010 In: LIVER TRANSPLANTATION. - 1527-6465. ; 16:6, s. S77-S77 Conference paper (other academic/artistic)
3.	Mergental, H, et al. (author) Liver transplantation for unresectable hepatocellular carcinoma in normal livers 2012 In: Journal of hepatology. - : Elsevier BV. - 1600-0641 .- 0168-8278. ; 57:2, s. 297-305 Journal article (peer-reviewed)
4.	Saner, F, et al. (author) Terlipressin and gelafundin : safe therapy of hepatorenal syndrome. 2004 In: European Journal of Medical Research. - 0949-2321 .- 2047-783X. ; 9:2, s. 78-82 Journal article (peer-reviewed)abstract BACKGROUND AND AIM: Hepatorenal syndrome (HRS) occurs in about 20 % of patients with liver cirrhosis and ascites and is characterized by intensive renal vasoconstriction, low glomerular filtration rate but preserved tubular function and normal renal histology. The potential of terlipressin and albumin to reverse HRS after a time period of 14 days has already been shown. However, intravenous albumin is expensive (approximately 25 per 50 ml 20% albumin in Germany) and has limited availability in some settings. Therefore we used an artificial plasma substitute, Gelatinepolysuccinat, which is less expensive (approximately 12 per 500 ml). The aim of our present study was to examine the effects of terlipressin and Gelatinepolysuccinat on renal function and hemodynamics in a time period of six days.METHODS AND PATIENTS: Seven consecutive patients with cirrhosis and hepatorenal syndrome were included in a pilot study of terlipressin (6 mg /24 h iv) therapy associated with i.v. Gelatinepolysuccinat (Gelafundin 4% Infusionslösung, Company Braun, Mw: 30 000 D).RESULTS: In five of the seven patients treatment was associated with a marked reduction of serum creatinine after six days (3.85 +/- 0.44 mg/dl vs.1.9 +/- 0.32 mg/dl; p< 0.018). Creatinine clearance improved (20 +/- 8.8 ml/min vs. 43 +/- 11.7 ml/min; p<0.12). There was a remarkable improvement in circulatory function in all patients, with an increase in mean arterial pressure (58+/-4.4 mmHg vs. 75 +/- 4.5 mmHg, p< 0.001). No patient developed signs of intestinal, myocardial or distal ischemia.CONCLUSIONS: Terlipressin and Gelatinepolysuccinat appear to be a safe and effective treatment of hepatorenal syndrome.
5.	Sarquis, MS, et al. (author) High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas 2006 In: The Journal of clinical endocrinology and metabolism. - : The Endocrine Society. - 0021-972X .- 1945-7197. ; 91:1, s. 262-269 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-5 of 5

Refine your search

Type of publication: journal article (3); conference paper (2)

Type of content: peer-reviewed (3); other academic/artistic (2)

Author/Editor: Ericzon, BG (3); Porte, RJ (3); Adam, R. (3); Klempnauer, JL (3); Kalicinski, P (3); Hockerstedt, K (3); show more...; Mergental, H (3); Krawczyk, M. (2); Jamieson, N (2); Lerut, J (2); Mantion, G (2); Muiesan, P (2); Muhlbacher, F (2); Wolff, M. (2); Mazzaferro, V. (2); Rogiers, X (2); Broelsch, CE (2); Le Treut, YP (2); Broelsch, C (2); Zedenius, J (1); Pirenne, J (1); Clavien, PA (1); Lang, H (1); Belghiti, J (1); Konigsrainer, A (1); Shen, L (1); Muehlbacher, F. (1); Weber, F (1); Eng, C (1); van Hoek, B (1); Detry, O (1); Wolf, P (1); Frilling, A. (1); Berenguer, M (1); Mirza, DF (1); Foss, A (1); Friman, S (1); Hop, WCJ (1); Malago, M (1); Burra, P (1); Langrehr, J (1); Filipponi, F. (1); Pisarski, P (1); Kobori, L (1); Castaing, D (1); Sellez, CF (1); Slooff, MJH (1); Fernandez-Sellez, C (1); Fangmann, J (1); Lohe, F (1); show less...

University: Karolinska Institutet (4); Uppsala University (1)

Language: English (5)

Research subject (UKÄ/SCB): Medical and Health Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view